Wave Life Sciences Ltd. (WVE)
↓ Download CSV- Sector Manufacturing
- Incorporated U0
- Fiscal year ends Dec 31
In fiscal 2025, Wave Life Sciences Ltd. reported revenue of $42.73M, down 60.5% from the prior year. The company ran a net loss, with a net margin of -478.3%. It held $638.50M in total assets against $112.27M in total liabilities.
Key ratios (FY2025)
-504.1%
Operating margin
-478.3%
Net margin
-39.4%
Return on equity
-60.5%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $42.73M | $108.30M | $113.31M | $3.65M | $40.96M | $20.08M | $15.98M | $14.41M | $3.89M | $1.09M |
| Operating Income | -$215.38M | -$110.40M | -$68.00M | -$162.72M | -$127.02M | -$153.38M | -$208.32M | -$159.52M | -$102.39M | -$55.72M |
| Net Income | -$204.38M | -$97.01M | -$57.51M | -$161.82M | -$122.25M | -$149.91M | -$193.64M | -$146.65M | -$101.98M | -$55.66M |
| EPS (Diluted) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | — | — | — | — | — |
| Total Assets | $638.50M | $352.21M | $274.95M | $146.39M | $207.01M | $279.24M | $284.25M | $295.94M | $181.84M | $164.81M |
| Total Liabilities | $112.27M | $134.82M | $227.44M | $183.60M | $166.63M | $188.59M | $212.64M | $214.72M | $34.36M | $22.07M |
| Shareholders' Equity | $518.36M | $209.51M | $39.63M | -$45.09M | $32.50M | $82.78M | $63.73M | $73.35M | $139.61M | $134.60M |
| Cash & Equivalents | $602.07M | $302.08M | $200.35M | $88.50M | $150.56M | $184.50M | $147.16M | $174.82M | $142.50M | $150.29M |
| Operating Cash Flow | -$187.49M | -$151.03M | -$19.43M | -$127.78M | -$88.99M | -$115.98M | -$188.23M | -$22.86M | -$83.67M | -$31.93M |
| Capital Expenditures | $718.0K | $938.0K | $1.11M | $1.36M | $560.0K | $1.34M | $3.92M | $9.94M | $18.89M | $5.57M |
| Shares Outstanding | 187.66M | 153.04M | 119.16M | 86.92M | 59.84M | 48.78M | 34.34M | 29.47M | 27.83M | 23.50M |